Hyperuricaemia in females with obstructive sleep apnoea (OSA)

R. Plywaczewski, M. Bednarek, L. Jonczak, J. Zielinski (Warsaw, Poland)

Source: Annual Congress 2003 - Clinical aspects and consequences of sleep related breathing disorders
Session: Clinical aspects and consequences of sleep related breathing disorders
Session type: Thematic Poster Session
Number: 656

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Plywaczewski, M. Bednarek, L. Jonczak, J. Zielinski (Warsaw, Poland). Hyperuricaemia in females with obstructive sleep apnoea (OSA). Eur Respir J 2003; 22: Suppl. 45, 656

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Hyperuricaemia in males with obstructive sleep apnoea (OSA)
Source: Eur Respir J 2001; 18: Suppl. 33, 334s
Year: 2001

Prevalence of nocturia in obstructive sleep apnoea (OSA)
Source: Eur Respir J 2006; 28: Suppl. 50, 646s
Year: 2006

NT-proBNP in obstructive sleep apnoea (OSA)
Source: Eur Respir J 2006; 28: Suppl. 50, 415s
Year: 2006

Obesity, obstructive sleep apnea (OSA) and asthma
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009


Prevalence of stroke in obstructive sleep apnoea (OSA) patients
Source: Eur Respir J 2007; 30: Suppl. 51, 331s
Year: 2007

Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010

Increased rates of obstructive sleep apnea (OSA) in COVID-19-patients
Source: Virtual Congress 2021 – Sleep across the lifespan in the new era of COVID - 19
Year: 2021


Masked hypertension and obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2006; 28: Suppl. 50, 416s
Year: 2006

Screening for obstructive sleep apnea (OSA) in acromegaly
Source: Virtual Congress 2020 – Screening methods and diagnostic tools for obstructive sleep apnoea
Year: 2020


Predictors of hypercapnia in obstructive sleep apnoea (OSA)
Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control
Year: 2010

Hypertension and obstructive sleep apnoea
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006


Cortisol metabolism in obstructive sleep apnea (OSA)
Source: Eur Respir J 2002; 20: Suppl. 38, 215s
Year: 2002

Effect of smoking on obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007


Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients
Source: Eur Respir J 2004; 24: Suppl. 48, 447s
Year: 2004

Daytime hypercapnia in patients with obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2002; 20: Suppl. 38, 493s
Year: 2002

Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007


Daytime ventilatory instability in obese patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2001; 18: Suppl. 33, 334s
Year: 2001

Cardiohemodynamics parameters in patients with COPD and obstructive sleep apnea, (OSA).
Source: International Congress 2017 – Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea
Year: 2017

Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008


Metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007